EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Neurokinin‐1 receptor antagonists for the prevention of postoperative nausea and vomiting

Tricia A Meyer iD, Ashraf S Habib iD, Deborah Wagner, Tong J Gan

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2023-09 · 43 (9) · 922-934

DOI: 10.1002/phar.2814 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, online erschienen am 19.06.2023. Verfasst von Tricia A Meyer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Texas A&M College of Medicine, Temple, Texas, USA. Hauptthemen laut MEDLINE: Postoperative Nausea and Vomiting, Antiemetics. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the availability of several classes of antiemetics, postoperative nausea and vomiting (PONV) remains a substantial burden for patients following surgery, resulting in patient dissatisfaction and prolonged stays in post‐anesthesia care units and ultimately increasing the cost of care. Enhanced recovery protocols and PONV management guidelines are now centered on the assessment of the individual patient's risk for developing PONV, as well as multimodal prophylaxis using antiemetics targeting different mechanisms of action. Over the last two decades, the neurokinin‐1 receptor (NK1R) has emerged as a therapeutic target for the management of PONV. This review of the literature explains the role of the NK1R and its ligand—substance P—in vomiting, describes the pharmacologic and pharmacokinetic properties of NK1R antagonists (NK1RAs) and summarizes the clinical evidence supporting NK1RAs for PONV prophylaxis in patients undergoing surgery. In particular, we discuss the therapeutic application of NK1RA in PONV prophylaxis protocols owing to their advantages over other antiemetic classes in efficacy, duration of efficacy, safety, pharmacology, and ease of administration. Future studies will be aimed at further investigating the efficacy and safety of NK1RA‐based multimodal combinations, particularly among vulnerable populations (e.g., children and elderly).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Postoperative Nausea and VomitingAntiemeticsChildHumansAgedNeurokinin-1 Receptor AntagonistsDrug Therapy, Combination

Stichwörter der Autor:innen

NK1RAPONVanesthesianeurokinin-1 receptor antagonistpostoperative nausea and vomitingprophylaxis

Substanzen

AntiemeticsNeurokinin-1 Receptor Antagonists

Autor:innen und Institutionen

  • Department of Anesthesiology, Texas A&M College of Medicine, Temple, Texas, USA.
  • Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Department of Anesthesiology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
  • Division of Anesthesiology, Critical Care and Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Tricia A Meyer, Ashraf S Habib

Zitieren

APA

Meyer, T. A., Habib, A. S., Wagner, D., & Gan, T. J. (2023). Neurokinin‐1 receptor antagonists for the prevention of postoperative nausea and vomiting. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 43(9), 922-934. https://doi.org/10.1002/phar.2814

Vancouver

Meyer TA, Habib AS, Wagner D, Gan TJ. Neurokinin‐1 receptor antagonists for the prevention of postoperative nausea and vomiting. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2023;43(9):922-934. doi:10.1002/phar.2814

BibTeX
@article{Meyer2023,
  author = {Meyer, Tricia A and Habib, Ashraf S and Wagner, Deborah and Gan, Tong J},
  title = {Neurokinin‐1 receptor antagonists for the prevention of postoperative nausea and vomiting},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2023},
  volume = {43},
  number = {9},
  pages = {922--934},
  doi = {10.1002/phar.2814}
}
Kostenlos starten →